{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:56:40Z","timestamp":1776959800405,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T00:00:00Z","timestamp":1297209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1743-422x-8-59","type":"journal-article","created":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T19:15:39Z","timestamp":1297278939000},"source":"Crossref","is-referenced-by-count":12,"title":["A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection"],"prefix":"10.1186","volume":"8","author":[{"given":"Alberto","family":"Monroy-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A","family":"G\u00f3mez-Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Weiss-Steider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina Paz-de","family":"la Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Hern\u00e1ndez-Montes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyna","family":"P\u00e9rez-Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yessica S","family":"Tapia-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel E","family":"Toledo-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edelmiro","family":"Santiago-Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor I","family":"Sanchez-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda deLourdes","family":"Mora-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"1165_CR1","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV: The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002, 55: 244-265.","journal-title":"J Clin Pathol"},{"key":"1165_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/PDM.0b013e3181c1482c","volume":"19","author":"MF Evans","year":"2010","unstructured":"Evans MF, Adamson CS, Schned LM, St John TL, Leiman G, Ashikaga T, Cooper K: HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests. Diagn Mol Pathol 2010, 19: 144-150. 10.1097\/PDM.0b013e3181c1482c","journal-title":"Diagn Mol Pathol"},{"key":"1165_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/CS20050369","volume":"110","author":"J Doorbar","year":"2006","unstructured":"Doorbar J: Molecular biology of human papillomavirus infection and cervical cancer. Clinical Science 2006, 110: 525-541. 10.1042\/CS20050369","journal-title":"Clinical Science"},{"key":"1165_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA: Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010, 10: 550-560. 10.1038\/nrc2886","journal-title":"Nat Rev Cancer"},{"key":"1165_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0042-6822(91)90772-4","volume":"185","author":"J Zhou","year":"1991","unstructured":"Zhou J, Sun XY, Stenzel DJ, Frazer IH: Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991, 185: 251-257. 10.1016\/0042-6822(91)90772-4","journal-title":"Virology"},{"key":"1165_CR6","doi-asserted-by":"publisher","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","volume":"89","author":"R Kirnbauer","year":"1992","unstructured":"Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc Natl Acad Sci USA 1992, 89: 12180-12184. 10.1073\/pnas.89.24.12180","journal-title":"Proc Natl Acad Sci USA"},{"key":"1165_CR7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/JVI.67.1.315-322.1993","volume":"67","author":"ME Hagensee","year":"1993","unstructured":"Hagensee ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 1993, 67: 315-322.","journal-title":"J Virol"},{"key":"1165_CR8","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JVI.67.4.1936-1944.1993","volume":"67","author":"RC Rose","year":"1993","unstructured":"Rose RC, Bonnez W, Reichman RC, Garcea RL: Expression of human papillomavirus type 11 L1 protein in insect cells in vivo and in vitro assembly of viruslike particles. J Virol 1993, 67: 1936-1944.","journal-title":"J Virol"},{"key":"1165_CR9","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1128\/JVI.77.17.9211-9220.2003","volume":"77","author":"S Biemelt","year":"2003","unstructured":"Biemelt S, Sonnewald U, Galmbacher P, Willmitzer L, Muller M: Production of human papillomavirus type 16 virus-like particles in transgenic plants. J Virol 2003, 77: 9211-9212. 10.1128\/JVI.77.17.9211-9220.2003","journal-title":"J Virol"},{"key":"1165_CR10","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1128\/CVI.00197-08","volume":"15","author":"H Ochi","year":"2008","unstructured":"Ochi H, Kondo K, Matsumoto K, Oki A, Yasugi T, Furuta R, Hirai Y, Yoshikawa H, Kanda T: Neutralizing antibodies against human papillomavirus types 16, 18, 31, 52, and 58 in serum samples from women in Japan with low-grade cervical intraepithelial neoplasia. Clin Vaccine Immunol 2008, 15: 1536-1540. 10.1128\/CVI.00197-08","journal-title":"Clin Vaccine Immunol"},{"key":"1165_CR11","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/315055","volume":"180","author":"L Wideroff","year":"1999","unstructured":"Wideroff L, Schiffman M, Haderer P, Armstrong A, Greer CE, Manos MM, Burk RD, Scott DR, Sherman ME, Schiller JT, Hoover RN, Tarone RE, Kirnbauer R: Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesions. J Infect Dis 1999, 180: 1424-1428. 10.1086\/315055","journal-title":"J Infect Dis"},{"key":"1165_CR12","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1086\/315498","volume":"181","author":"JJ Carter","year":"2000","unstructured":"Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA: Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 2000, 181: 1911-1919. 10.1086\/315498","journal-title":"J Infect Dis"},{"key":"1165_CR13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/CDLI.3.4.403-410.1996","volume":"3","author":"T Sasagawa","year":"1996","unstructured":"Sasagawa T, Inoue M, Lehtinen M, Zhang W, Gschmeissner SE, Hajibagheri MA, Finch J, Crawford L: Serological responses to human papillomavirus type 6 and 16 virus-like particles in patients with cervical neoplastic lesions. Clin Diagn Lab Immunol 1996, 3: 403-410.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1165_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1067\/mob.2002.121898","volume":"186","author":"K Heim","year":"2002","unstructured":"Heim K, Widschwendter A, Pirschner G, Wieland U, Awerkiew S, Christensen ND, Bergant A, Marth C, H\u00f6pfl R: Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer. Am J Obstet Gynecol 2002, 186: 705-711. 10.1067\/mob.2002.121898","journal-title":"Am J Obstet Gynecol"},{"key":"1165_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/CDLI.4.2.122-126.1997","volume":"4","author":"RP Viscidi","year":"1997","unstructured":"Viscidi RP, Kotloff KL, Clayman B, Russ K, Shapiro S, Shah KV: Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol 1997, 4: 122-126.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1165_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<529::AID-IJC7>3.0.CO;2-V","volume":"75","author":"T Sasagawa","year":"1998","unstructured":"Sasagawa T, Yamazaki H, Dong YZ, Satake S, Tateno M, Inoue M: Immunoglobulin- A and -G responses against virus-like particles (VLP) of human papillomavirus type in women with cervical cancer and cervical intra-epithelial lesions. Int J Cancer 1998, 75: 529-535. 10.1002\/(SICI)1097-0215(19980209)75:4<529::AID-IJC7>3.0.CO;2-V","journal-title":"Int J Cancer"},{"key":"1165_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1136\/bmj.312.7030.537","volume":"312","author":"M Lehtinen","year":"1996","unstructured":"Lehtinen M, Dillner J, Knekt P, Luostarinen T, Aromaa A, Kirnbauer R, Koskela P, Paavonen J, Peto R, Schiller JT, Hakama M: Serologically diagnosed infection with human papillomavirustype 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 1996, 312: 537-539.","journal-title":"BMJ"},{"key":"1165_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1067\/mob.2003.98","volume":"188","author":"M Lehtinen","year":"2003","unstructured":"Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen S, Dillner J: Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later. Am J Obstet Gynecol 2003, 188: 49-55. 10.1067\/mob.2003.98","journal-title":"Am J Obstet Gynecol"},{"key":"1165_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1006\/gyno.1998.4963","volume":"69","author":"JS Park","year":"1998","unstructured":"Park JS, Park DC, Kim CJ, Ahn HK, Um SJ, Park SN, Kim SJ, Namkoong SE: HPV-16-related proteins as the serologic markers in cervical neoplasia. Gynecol Oncol 1998, 69: 47-55. 10.1006\/gyno.1998.4963","journal-title":"Gynecol Oncol"},{"key":"1165_CR20","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/ijc.2910550515","volume":"55","author":"RP Viscidi","year":"1993","unstructured":"Viscidi RP, Sun Y, Tsuzaki B, Bosch FX, Munoz N, Shah KV: Serologic response in human papillomavirus-associated invasive cervical cancer. Int J Cancer 1993, 55: 780-784. 10.1002\/ijc.2910550515","journal-title":"Int J Cancer"},{"key":"1165_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1743-422X-6-2","volume":"6","author":"G Paz de la Rosa","year":"2009","unstructured":"Paz de la Rosa G, Monroy-Garc\u00eda A, Mora-Garc\u00eda ML, Reynaga Pe\u00f1a CG, Hern\u00e1ndez-Montes J, Benny Weiss-Steider B, G\u00f3mez Lim MA: An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice. Virol J 2009, 6: 2. 10.1186\/1743-422X-6-2","journal-title":"Virol J"},{"key":"1165_CR22","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1099\/vir.0.80077-0","volume":"85","author":"L Rocha-Zavaleta","year":"2004","unstructured":"Rocha-Zavaleta L, Ambrosio JP, Mora-Garcia ML, Cruz-Talonia F, Hernandez-Montes J, Weiss-Steider B, Ortiz-Navarrete V, Monroy-Garcia A: Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low- risk HPV-associated low-grade squamous intraepithelial lesions. J Gen Virol 2004, 85: 2643-2650. 10.1099\/vir.0.80077-0","journal-title":"J Gen Virol"},{"key":"1165_CR23","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/00365540903501608","volume":"42","author":"J Palmroth","year":"2010","unstructured":"Palmroth J, Namujju P, Simen-Kapeu A, Kataja V, Surcel HM, Tuppurainen M, Yliskoski M, Syrj\u00e4nen K, Lehtinen M: Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes. Scand J Infect Dis 2010, 42: 379-384. 10.3109\/00365540903501608","journal-title":"Scand J Infect Dis"},{"key":"1165_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/infdis\/174.5.927","volume":"174","author":"JJ Carter","year":"1996","unstructured":"Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, Kuypers J, Kiviat N, Galloway DA: The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996, 174: 927-936.","journal-title":"J Infect Dis"},{"key":"1165_CR25","first-page":"877","volume":"9","author":"M Nakagawa","year":"2002","unstructured":"Nakagawa M, Viscidi R, Deshmukh I, Costa MD, Palefsky JM, Farhat S, Moscicki AB: Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women. Clin Diagn Lab Immunol 2002, 9: 877-882.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1165_CR26","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1128\/JVI.69.8.5147-5151.1995","volume":"69","author":"RB Roden","year":"1995","unstructured":"Roden RB, Hubbert NL, Kirnbauer R, Breitburd F, Lowy DR, Schiller J: Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol 1995, 69: 5147-5151.","journal-title":"J Virol"},{"key":"1165_CR27","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1158\/1535-7163.MCT-07-2015","volume":"7","author":"T Bian","year":"2008","unstructured":"Bian T, Wang Y, Lu Z, Ye Z, Zhao L, re J, Zhang H, Ruan L, Tian H: Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice. Mol Cancer Ther 2008, 7: 1329-1335. 10.1158\/1535-7163.MCT-07-2015","journal-title":"Mol Cancer Ther"},{"key":"1165_CR28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/0042-6822(92)90453-V","volume":"187","author":"M M\u00fcller","year":"1992","unstructured":"M\u00fcller M, Viscidi RP, Sun Y, Guerrero E, Hill PM, Shah F, Bosch FX, Mu\u00f1oz N, Gissmann L, Shah KV: Antibodies to HPV-16 E6 and E7 proteins as markers for HPV- 16 associated invasive cervical cancer. Virology 1992, 187: 508-514.","journal-title":"Virology"},{"key":"1165_CR29","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/jmv.2098","volume":"65","author":"R Rosales","year":"2001","unstructured":"Rosales R, L\u00f3pez-Contreras M, Cortes RR: Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA. J Med Virol 2001, 65: 736-44. 10.1002\/jmv.2098","journal-title":"J Med Virol"},{"key":"1165_CR30","first-page":"50","volume":"74","author":"SD Vernon","year":"1997","unstructured":"Vernon SD, Unger ER, Miller DL, Lee DR, Reeves WC: Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival From cervical cancer. In J Cancer 1997, 74: 50-56.","journal-title":"In J Cancer"},{"key":"1165_CR31","first-page":"615","volume":"8","author":"M Papenfuss","year":"1999","unstructured":"Papenfuss M, Schneider A, Nour M, Hatch K: Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev 1999, 8: 615-620.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1165_CR32","first-page":"397","volume":"15","author":"EM Smith","year":"1991","unstructured":"Smith EM, Johnson SR, Jiang D, Zaleski S, Lynch CF, Brundage S, Anderson RD, Turek LP: The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev 1991, 15: 397-402.","journal-title":"Cancer Detect Prev"},{"key":"1165_CR33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1128\/JCM.36.2.475-480.1998","volume":"36","author":"W Meschede","year":"1998","unstructured":"Meschede W, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, Gissmann L, Pawlita M: Antibodies against early proteins of human papillomavirus as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998, 36: 475-480.","journal-title":"J Clin Microbiol"},{"key":"1165_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1750-9378-1-6","volume":"1","author":"P Di Bonito","year":"2006","unstructured":"Di Bonito P, Grasso F, Mochi S, Accardi L, Don\u00e0 MG, Branca M, Costa S, Mariani L, Agarossi A, Ciotti M, Syrj\u00e4nen K, Giorgi C: Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins. Infect Agent Cancer 2006, 1: 6. 10.1186\/1750-9378-1-6","journal-title":"Infect Agent Cancer"},{"key":"1165_CR35","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1093\/jnci\/81.22.1698","volume":"81","author":"I Jochmus-Kudielka","year":"1989","unstructured":"Jochmus-Kudielka I, Schneider A, Braun R, Kimmig R, Koldovsky U, Schneweis KE, Seedorf K, Gissmann L: Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 1989, 81: 1698-1704. 10.1093\/jnci\/81.22.1698","journal-title":"J Natl Cancer Inst"},{"key":"1165_CR36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1128\/JCM.29.8.1579-1588.1991","volume":"29","author":"C Bleul","year":"1991","unstructured":"Bleul C, M\u00fcller M, Frank R, Gausepohol U, Koldovsky U, Mgaya HN, Luande J, Pawlita M, Meulen JT, Viscidi R, Gissmann L: Human papillomavirus type 18 E6 and E7 antibodies in human sera: Increased anti-E7 prevalence in cervical cancer patients. J Clin Microbiol 1991, 29: 1579-1588.","journal-title":"J Clin Microbiol"},{"key":"1165_CR37","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/1097-0142(19941015)74:8<2307::AID-CNCR2820740815>3.0.CO;2-X","volume":"74","author":"KN Gaarenstroom","year":"1994","unstructured":"Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Gallee MP, Hart AA, M\u00fcller M, Trimbos JB, Helmerhorst TJ: Prognostic significance of serum antibodies to human papillomavirus-16 E4 and E7 peptides in cervical cancer. Cancer 1994, 74: 2307-2313. 10.1002\/1097-0142(19941015)74:8<2307::AID-CNCR2820740815>3.0.CO;2-X","journal-title":"Cancer"},{"key":"1165_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/vim.2009.0055","volume":"22","author":"ZA Malik","year":"2009","unstructured":"Malik ZA, Hailpern SM, Burk RD: Persistent antibodies to HPV virus-like particles following natural infection are protective against subsequent cervicovaginal infection with related and unrelated HPV. Viral Immunol 2009, 22: 445-449. 10.1089\/vim.2009.0055","journal-title":"Viral Immunol"},{"key":"1165_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/00003081-196712000-00002","volume":"10","author":"RM Richardt","year":"1968","unstructured":"Richardt RM: Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968, 10: 748-784.","journal-title":"Clin Obstet Gynecol"},{"key":"1165_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/jmv.1890440419","volume":"44","author":"JN Kaye","year":"1994","unstructured":"Kaye JN, Cason J, Pakarian FB, Jewers RJ, Kell B, Bible J, Raju KS, Best JM: Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child. J Med Virol 1994, 44: 415-421. 10.1002\/jmv.1890440419","journal-title":"J Med Virol"},{"key":"1165_CR41","first-page":"209","volume":"7","author":"MM Manos","year":"1989","unstructured":"Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM: Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989, 7: 209-214.","journal-title":"Cancer Cells"},{"key":"1165_CR42","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1128\/JCM.34.9.2095-2100.1996","volume":"34","author":"F Karlsen","year":"1996","unstructured":"Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B, Hagmar B: Use of multiple PCR primer sets for optimal detection of Human papillomavirus. J Clin Microbiol 1996, 34: 2095-2100.","journal-title":"J Clin Microbiol"},{"key":"1165_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/324163a0","volume":"324","author":"RA Saiki","year":"1986","unstructured":"Saiki RA, Bugawan TL, Horn GT, Mullis KB, Erlich HA: Analysis of enzymatically amplified b-globin and HLA DQ alpha DNA with allele specific oligonucleotide probes. Nature 1986, 324: 163-166. 10.1038\/324163a0","journal-title":"Nature"},{"key":"1165_CR44","first-page":"1","volume-title":"Advances in Cancer Research at UNAM (Universidad Nacional Aut\u00f3noma de M\u00e9xico)","author":"A Monroy-Garc\u00eda","year":"2007","unstructured":"Monroy-Garc\u00eda A, Hern\u00e1ndez-Montes J, Mora-Garc\u00eda ML: Identification of epitopes from L1, E6, and E7 proteins of the HPV-16 and 18 types and its implication for diagnosis and treatment of cervical carcinoma. In Advances in Cancer Research at UNAM (Universidad Nacional Aut\u00f3noma de M\u00e9xico) Edited by: Jaime Mas Oliva. 2007, 1-32. Manual Moderno, UNAM, ISBN 970-32-4283-9;"},{"key":"1165_CR45","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.4049\/jimmunol.154.11.5934","volume":"154","author":"ME Ressing","year":"1995","unstructured":"Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ: Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA- A*0201-binding peptides. J Immunol 1995, 154: 5934-5943.","journal-title":"J Immunol"},{"key":"1165_CR46","first-page":"483","volume":"11","author":"AS Kadish","year":"2002","unstructured":"Kadish AS, Timmins P, Wang Y, Ho GY, Burk RD, Ketz J, He W, Romney SL, Johnson A, Angeletti R, Abadi M: Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 2002, 11: 483-488.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1165_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1440-1711.2003.01130.x","volume":"81","author":"V Khammanivong","year":"2003","unstructured":"Khammanivong V, Liu XS, Liu WJ, Rodda SJ, Leggatt GR, Tndle RW, Frazer IH, Fernando GJ: Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunol Cell Biol 2003, 81: 1-7. 10.1046\/j.1440-1711.2003.01130.x","journal-title":"Immunol Cell Biol"},{"key":"1165_CR48","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0165-2478(98)00188-6","volume":"67","author":"A Monroy-Garc\u00eda","year":"1999","unstructured":"Monroy-Garc\u00eda A, Ort\u00edz-Navarrete VF, Mora-Garc\u00eda ML, Flores-Borja F, Diaz-Qui\u00f1onez A, Isibasi-Araujo A, Trejo-Becerril C, Chac\u00f3n-Salinas R, Hern\u00e1ndez-Montes J, Granados-Arreola J, de Leo C, Weiss-Steider B: Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection. Immunol Lett 1999, 67: 167-177.","journal-title":"Immunol Lett"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1743-422X-8-59\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T04:54:24Z","timestamp":1685940864000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-59","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,9]]},"article-number":"59"}}